Device Registry in Saudi Arabia: What Have We Learned. Ahmad Hersi

Similar documents
PERFORMANCE MEASURE TECHNICAL SPECIFICATIONS. HRS-3: Implantable Cardioverter-Defibrillator (ICD) Complications Rate

ICD: Basics, Programming and Trouble-shooting

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Daily practice of ACS management in the Gulf: Data from Gulf COAST

CAPTIVATE SUMMARY CLINICAL SUMMARY. CAPTure Information Via Automatic Threshold Evaluation

(auto) à If Yes, Most Recent LVEF Date 4155 : à If Yes, Most Recent LVEF 4160 :

Shock Reduction Strategies Michael Geist E. Wolfson MC

Tachycardia Devices Indications and Basic Trouble Shooting

King Saud University Faculty of Medicine P. O. Box Riyadh, King Saud University, Riyadh, KSA

3/17/2014. WS # 3 ICD Registry Case Scenarios with Structural Abnormalities. Objectives. Denise Pond BSN, RN

Inappropriate electrical shocks: Tackling the beast

INNOVATIONS IN DEVICE THERAPY:

3/17/2014. NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death. Objectives

CRF procedure PROCEDURE FLOW. PATIENT ASSESSMENT Symptoms and indication. Pacemaker & ICD registration. Procedures. Procedure ICD.

Cardiac resynchronisation therapy (biventricular pacing) for the treatment of heart failure

DECREASE-HF CLINICAL SUMMARY

ESC Stockholm Arrhythmias & pacing

EPIDEMIOLOGY OF CANCER IN THE GULF REGION. Khoja, T. 1, Zahrani A. 2

The Nuts and Bolts of ICD Therapy

Troubleshooting ICD. NASPE Training Lancashire & South Cumbria Cardiac Network

Device Interrogation- Pacemakers, ICD and Loop Recorders. Dulce Obias-Manno, RN, MHSA, CCDS,CEPS, FHRS Device Clinic Coordinator, MHVI

Device Update Implantable Cardioverter Defibrillator (ICD) 박상원

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm

Tech Corner. ATP in the Fast VT zone

Advanced ICD Concepts

Abbreviation List: 2017 by the American Heart Association, Inc. and the American College of Cardiology Foundation. 1

CLINICAL SUMMARY COGENT-4 FIELD FOLLOWING STUDY

Primary Therapy for High Risk LQT Patients Should Be an ICD

Supplementary Online Content

Leadless pacemakers and subcutaneous ICD s: will we use them for most of our patients? K.-H. Kuck Asklepios Klinik St. Georg Hamburg, Germany

MEDICAL POLICY Cardioverter Defibrillators

White Paper: Reducing Overutilization of Implantable

Do All Patients With An ICD Indication Need A BiV Pacing Device?

Implantable cardioverter defibrillator, Inappropriate shock, Lead failure

Response of Right Ventricular Size to Treatment with Cardiac Resynchronization Therapy and the Risk of Ventricular Tachyarrhythmias in MADIT-CRT

Leadless Pacing. Osama Diab Assistant Prof. of Cardiology Ain Shams University Egypt

PACEMAKER INTERPRETATION AND DEVICE MANAGEMENT PART II

New generations pacemakers and ICDs: an update

CONTAK RENEWAL 3 AVT CLINICAL SUMMARY

Mohammad Zubaid, MB, ChB, FRCPC, FACC

Endovascular Stroke Treatment in the Developing World

ICD Discrimination Algorithms

Mahmoud Suleiman MD. On behalf of the Israeli ICD Registry Scientific Committee. Jan 11, National ICD Registry

Continuous ECG telemonitoring with implantable devices: the expected clinical benefits

The role of internist in heart failure management bridging the quality gaps

Essentials of Pacemakers and ICD s. Rajesh Banker, MD, MPH

Atrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice

LONGITUDINAL SURVEILLANCE REGISTRY OF ACUITY SPIRAL LEAD

Vest Prevention of Early Sudden Death Trial (VEST)

A Closer Look Product Education at a glance

MADIT Studies: CRT in the Non-LBBB Patient and Other Findings. Arthur J. Moss, MD

Revisions to the BC Guide for Physicians in Determining Fitness to Drive a Motor Vehicle

EnTrust D154VRC Single Chamber ICD 35J delivered 8 seconds BOL, 11.8 seconds ERI 10.7 years**** 35cc, 68g Programmable Active Can

THE ROLE OF ICD THERAPY FOR PRIMARY PREVENTION Leonard Ganz, M.D. Pittsburgh, PA

Sudden death as co-morbidity in patients following vascular intervention

Sudden Cardiac Death and Asians Disclosures

Selecting the Best ICD for your Patient-SICD v. TV. Martin C. Burke DO, FACOI CorVita Science Foundation & Academic Medical Center, Amsterdam

The ACC Heart Failure Guidelines

NEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS

Device Implantation: Long-Term Commitments. Fayez Bokhari, MD, FRCPC Director of Cardiology Military Hospital, Jeddah

Subcutaneous ICD Emerging Role of Sudden Cardiac Death Prevention

Tachyarrhythmia Suspicion and Detection

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist

Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)

Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, M.D.

Riata lead extraction- a single centre experience

CARDIAC DEVICE MR-CONDITIONAL PRODUCT SUMMARY CHART

Riata Lead Summit Jan 20, SJM Perspective Dr. Mark Carlson

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)

Treatment of VT of Purkinje fiber origin: ablation targets and outcome

SPORTS AND EXERCISE ADVICE IN PATIENTS WITH ICD AND PPM

NHS. Implantable cardioverter defibrillators (ICDs) for arrhythmias. National Institute for Health and Clinical Excellence. Issue date: January 2006

Cardiac Implanted Electronic Devices Pacemakers, Defibrillators, Cardiac Resynchronization Devices, Loop Recorders, etc.

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

Sudden Cardiac Death

Policy #: 168 Latest Review Date: October 2014

Management of Arrhythmias The General Practitioners role

Primary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life

The SEPTAL CRT study (NCT: )

EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs

Polypharmacy - arrhythmic risks in patients with heart failure

EACTS Adult Cardiac Database

Medical Department- Faculty of medicine-sanaa university Cardiac Center- Al-thawrah Modern General teaching Hospital

How to treat Cardiac Resynchronization Therapy complications? C. Leclercq Departement of Cardiology Centre Cardio-Pneumologique Rennes, France

Danish Pacemaker and ICD Register Annual report 2015

Risk Stratification of Sudden Cardiac Death

The Counter HF Clinical Study for Heart Failure

Preventing Sudden Death Current & Future Role of ICD Therapy

John H. Ip, M.D FACC Associate Professor of Medicine Michigan State University Medical Director, EP Service

Programming of Bradycardic Parameters. C. W. Israel, M.D. Dept. of Cardiology Evangelical Hospital Bielefeld Germany

Who does not need a primary preventive ICD?

The EFFORTLESS SICD Registry. The EFFORTLESS SICD Registry. SICD Implant 11/14/2016

Implantable Cardioverter- Defibrillators (ICDs) for the Prevention of SCD: Appropriate Use in Disclosures

Remote monotoring of cardiac rhythm devices: present and future Pacemaker and ICD

Editorial TREATMENT OF SUDDEN CARDIAC DEATH SURVIVORS: DRUGS VERSUS DEVICE

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

Call Medtronic at 1 (800) to verify the patient s current implanted system

ICD THERAPIES: are they harmful or just high risk markers?

Dipen Shah Cardiology Service, University Hospitals, Geneva Switzerland

Defibrillation Testing should be routinely performed at the time of ICD implantation. Jeff Healey MD, MSc, FHRS McMaster University

Transcription:

Device Registry in Saudi Arabia: What Have We Learned Ahmad Hersi

GULF IMPLANTABLE CARDIOVERTER- DEFIBRILLATOR STUDY (Gulf ICD)

Gulf ICD Steering Committee Alawi Alsheikh-Ali (Co-PI) Adel Khalifa [Co-PI] Bahrain Abdulmohsen Al-Musaed KSA Bandar Al-Ghamdi KSA Fayez Bokhari KSA Najib Al-Rawahi Oman Fawziya Al-Kandari Kuwait Salem Alkaabi UAE Hosam Zaky UAE Ahmad Hersi [Co-PI] KSA Ahmad Al-Fagih KSA Faisal Al-Samadi KSA Mohammad Almehairi - UAE Amin Daoulah KSA Nidal Asaad Qatar Omer Elhag UAE Hani Sabbour UAE

What we know about ICDs in the Gulf 1. Hersi, A. Implantable Cardioverter Defibrillator Therapy: A single Center Experience in Saudi Arabia. Cardio Med J, 2010, 4, 192-197 2. Daoulah A, Alsheikh-Ali AA, Ocheltree A, et. al. Outcome after Implantable Defibrillator in Patients with Brugada Syndrome: The Gulf Brugada Syndrome Registry. Journal of Electrocardiology 2012. 45(3):327-32. 3. Alsheikh-Ali AA, Alkaabi S, Elhag O, et. al. The Implantable Cardioverter- Defibrillator in the United Arab Emirates: Preliminary Findings of a National Survey [Abstract]. Circulation 2012. 125(19): P515. 4. Al Rawahi N, Al Kalbani A. Indications for Cardiac Devices Implantation in Oman [Abstract]. Circulation 2012. 125(19): P518.

Gulf ICD in a Nut Shell A prospective observational multi-center multi-national study of the characteristics and outcomes of patients receiving de novo implantable cardioverter-defibrillators (ICD) in the Arabian Gulf region. Original enrolment target = 1,000 patients; extended to 1,500. Data on baseline clinical characteristics, ICD programming parameters, inpatient outcomes, and clinical events such as mortality and ICD discharges over 1 year of follow-up will be collected. Enrolment complete, Follow-up on-going

Subject Selection Inclusion Criteria All adult patients 18 years or older, receiving a new ICD implant and willing to sign a consent form will be eligible. Exclusion Criteria Patients < 18 years and those not willing to sign a consent form. Subjects with existing ICDs undergoing pulse generator replacements or system revisions will not be included.

Sample Size Considerations We wanted to ensure adequate precision around two key outcomes: all-cause mortality and rate of appropriate ICD discharges at one year. To estimate an event rate of 10% at 1 year with a margin of error of 2% and 95% confidence intervals, a sample size of 829 patients is required. Since there is little guidance in the literature on such event rates among ICD recipients in the Gulf, and to compensate for losses to follow-up, we adjusted our sample size upwards to 1,000 patients. Such a sample size was considered logistically feasible given our experience with ICD implant rates in the Gulf.

Sample Size Considerations Sample size would allow for adequate precision (not more than 2% error margin with 95% confidence level) across a wide range of expected event rates

Data Variables & Definitions Definitions based on the ACC/AHA/HRS 2006 Key Data Elements and Definitions for Electrophysiological Studies and Procedures and the ACC National Cardiovascular Data Registry (NCDR) ICD Registry data dictionary

Timelines 1 st pt. Jan. 2014 Last pt. July 2015 1-year FU July 2016

Gulf ICD Registry Baseline CRF [Page 7/10] F. ICD Programming Cont d Number of Tachy Therapy Zones 1 2 3 Zone 1 Rate Cut-Off (bpm) ATP Programmed Yes No Zone 2 Rate Cut-Off (bpm) ATP Programmed Yes No Zone 3 Rate Cut-Off (bpm) ATP Programmed Yes No Ventricular Tachyarrhythmia Detection Criteria Medtronic Device: Initial Beats to Detect. Zone 1 VF 12/16 18/24 24/32 30/40 45/60 60/80 75/100 90/120 105/140 120/160 Zone 2 FVT Via VF Via VT Zone 3 VT St. Jude Medical Device: Intervals to Detect (enter number). Zone 1 VF Zone 2 VT Zone 3 VT Boston Scientific Device: Time to Detection (enter seconds) Zone 1 VF Zone 2 VT Zone 3 VT Biotronic Device: Detection Counter. Zone 1 VF 6/8 8/12 10/14 12/16 16/20 18/24 20/26 22/30 24/30 Zone 2 VT Zone 3 VT Gulf ICD CRF v.08.12.2013

Gulf ICD Registry Baseline CRF [Page 8/10] G. ADVERSE EVENTS Adverse Event Yes No Cardiac Arrest Yes No Drug Reaction Yes No Cardiac Perforation Yes No Coronary Sinus Dissection Yes No Pocket Hematoma Yes No If Pocket Hematoma: Requiring Evacuation Requiring Transfusion Lead Dislodgment Yes No TIA Yes No CVA/Stroke Yes No MI Yes No Pericardial Tamponade Yes No If Yes, Complete Below: If Yes, Date: DD MM YYYY If Yes, Date: DD MM YYYY If Yes, Date: DD MM YYYY If Yes, Date: DD MM YYYY If Yes, Date: DD MM YYYY If Yes, Date: DD MM YYYY If Yes, Date: DD MM YYYY If Yes, Date: DD MM YYYY If Yes, Date: DD MM YYYY If Yes, Date: DD MM YYYY Pocket Infection Yes No If Yes, Date: DD MM YYYY Pneumothorax Yes No If Yes, Date: DD MM YYYY Hemothorax Yes No If Yes, Date: DD MM YYYY Yes Yes No No Gulf ICD CRF v.08.12.2013

Gulf ICD Registry Follow Up CRF [Page 1/1] A. IDENTIFICATION Unique Gulf ICD Number Initials Hospital File Number F M L B. Follow Up Data Follow Up Date DD MM YYYY Follow Up No. Follow Up Type Patient Visit Telephone Call Medical Record Review C. Interim Events Death Yes No Syncope Yes No If Yes, Date: If Yes, Date: Appropriate ICD Discharge Yes No If Yes, Date: If Yes Inappropriate ICD Discharge Yes No If Yes, Date: If Yes VF VT Cycle Length (msec) AF SVT/AT Sinus Tach T-wave oversensing Lead Fracture External Noise Other [ ] ICD Malfunction Yes No If Yes, Date: If Yes Pulse Generator Malfunction Lead Fracture Other [.. ] DD MM YYYY DD MM YYYY DD MM YYYY DD MM YYYY DD MM YYYY Gulf ICD CRF v.08.12.2013

Active Centers Saudi Arabia Prince Sultan Cardiac Center Prince Salman Heart Center King Fahad Armed Forces Hospital Jeddah King Khalid University Hospital King Faisal Specialist Hospital and Research Center - Riyadh King Abdulaziz Medical City National Guard King Faisal Specialist Hospital Jeddah UAE Kuwait Sheikh Khalifa Medical City Zayed Military Hospital Dubai Hospital Chest Hospital Kuwait Heart Center Dabbous Cardiac Center 6 Countries 15 Centers Oman Royal Hospital Bahrain Bahrain Defense Force Hospital Qatar Hamad Medical Corporation

Site Survey

Site Survey 14(93%) 1(7%)

Site Survey

Site Survey

Enrollment Rate 1600 1500 1400 1300 1200 1100 1000 900 800 700 600 500 400 300 200 100 0 Enrolled Per Month Total Enrollment = 1,545 Monthly enrollment (since launch) = ~ 77 Monthly enrollment (past 12 months) = ~ 88 Cumulative Enrolled 200 180 160 140 120 100 80 60 40 20 0 # Sites 1 5 9 12 13 14 14 15 15 15

Enrolment by Country & Center (n=1,545) Bahrain Defence Force Hospital Bahrain 55 55 Gulf ICD Enrolment 3% 3% 5% Hamad Medical Corporation Qatar Royal Hospital Oman Dabbous Cardiac Center Chest Hospital Kuwait 60 60 80 80 28 75 103 71% 7% 11% Qatar Bahrain Oman Kuwait UAE KSA Dubai Hospital Zayed Military Hospital SKMC UAE KFSH - Jeddah KFSHRC - Riyadh King Khalid University King Fahad Armed Forces - Jeddah King Abdulaziz Medical City Prince Salman Heart Center Prince Sultan Cardiac Center Saudi Arabia 8 38 117 163 29 75 120 138 160 227 Gulf Population 335 59% 4% 3% 1084 0 200 400 600 800 1000 1200 8% 7% 19% Qatar Bahrain Oman Kuwait UAE KSA

Baseline Characteristics Variable N = 1,545 Demographics Age (years) 57 ± 14 Age 65 (years) 70% Male 83% Gulf Nationals 71% Insurance Government 89% Private 5% Charity 3% Self Pay 3%

Baseline Characteristics Variable N = 1,545 Co-Morbidities LVEF 27 ± 11 LVEF 35 89% Diabetes Mellitus 57% Hypertension 62% CHF 71% Prior MI 40% Atrial Fibrillation 14% Prior Stroke 5% Past Smoker 24% Present Smoker 16%

Baseline Characteristics Variable N = 1,545 Implant Characteristics Primary Prevention 80% Elective Admission 55% Pre-implant EPS 3% DFT Testing 4% Single/Dual/CRT-D 47%/20%/33% Single Coil RV Lead 50% Manufacturer Medtronic 66% SJM 15% Boston Scientific 14% Biotronik 5%

Baseline Characteristics Variable N = 1,545 In-Hospital Outcomes Complications 1.2% Mortality 0.4%

The estimated average national ICD implant rate in the Arabian Gulf region is ~ 40 per million.

Adherence to Evidence-Based Criteria for the Implantation of primary Prevention ICD Data from the US suggest that ~ 1 in 4 ICD implants do not meet these evidence-based criteria for implantation 705 receiving ICD 122(17%) did not meet the evidence based criteria In the Gulf-ICD 1 in 6 ICD do not meat the criteria

Adherence to Evidence-Based Criteria for the Implantation of primary Prevention ICD Recent diagnosis of heart failure (n=91, 75%) Recent MI (n=26, 21%), NYHA Class IV (n=17, 15%), Recent CABG (n=10, 8%).

Concussions Arabian Gulf patients receive ICD at younger age than western counterpart. Low rate of implantation of ICD per 1 M of the population

Funding